Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World StudyLulu Zhao, Yingtai Chen, Yongliang Fu et al.|The Oncologist|2023Cited by 7
The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of dataLulu Zhao, Yingtai Chen, Fan Zhang et al.|BMC Cancer|2023Cited by 5
The Minimum Number of Examined Lymph Nodes was 24 for Optimal Survival of Pathological T2-4 Gastric Cancer: a multi-center, hospital-based study covering 20 years of dataLulu Zhao, Yingtai Chen, Fan Zhang et al.|Research Square|2023Cited by 1
A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Updated interim analysis from the NER-Tree study.Xiaojia Wang, Jin Zhang, Xinhong Wu et al.|Journal of Clinical Oncology|2025Cited by 0
Abstract P5-07-19: A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in Human Epidermal Growth Factor Receptor 2 positive (HER2+) early breast cancer (EBC) in China: NER-Tree study—An interim analysis on safetyJin Zhang, Xiaojia Wang, Haiguang Liu et al.|Clinical Cancer Research|2025Cited by 0